Some of the stock prices in the July 2, 2001, issue of BioWorld Financial Watch, both in the stock tables and the front-page numbers, were reported incorrectly due to errors from Nasdaq on June 29. The number in today's issue use the corrected closing prices provided later by Nasdaq, not the erroneous prices initially reported. Affected companies were Invitrogen Corp., Aclara BioSciences Inc., Transgenomic Inc., V.I. Technologies Inc., AVI BioPharma Inc., Curis Inc., Miravant Medical Technologies and Emisphere Technologies.

No Comments